Literature DB >> 24570695

Large coronary artery fistula and patent ductus arteriosus: transcatheter closure with three PDA nitinol wire mesh occluders.

Jacek Bialkowski1, Malgorzata Szkutnik1, Gejung Zhang2, Shilinag Jiang2.   

Abstract

Coronary artery fistulas (CAF) are the most common congenital anomaly of this vessel. We present the case of a 26-year-old man with two coexisting congenital cardiac defects: patent ductus arteriosus (PDA) and CAF. The patient 3 months earlier had the transcatheter PDA closed (type A, diameter 4 mm) with a 10/8 mm PDA nitinol wire mesh occluder. After the procedure he continued to have symptoms of fatigue and continuous murmur in the precordial region persisted. In angio-CT a large coronary fistula from the circumflex coronary artery with suspicion of multiple orifices to the right atrium was found. An arteriovenous wire loop was created (guidewire introduced from the aorta through the CAF was snared using a lasso catheter in the superior vena cava and exteriorized through the right femoral vein). Retrogradely an 8 F long sheath and delivery system was introduced to the end of the fistula and a 12/10 mm Cardio-O-Fix PDA occluder (Starway Comp, China, Beijing) was implanted, closing one orifice of the CAF. Another leak (orifice of CAF - 3.5 mm diameter) was closed using a similar technique with a 10/8 mm PDA Cardio-O-Fix device. Complete closure of the coronary artery fistula and disappearance of the heart murmur were observed after the procedure. The patient was discharged home 4 days later on acetylsalicylic acid 150 mg/day. During 6 months of follow-up he was doing well without any complaints or pathological symptoms. In control angio-CT performed 3 months after the procedure complete closure of the CAF was confirmed.

Entities:  

Keywords:  coronary artery fistula; patent ductus arteriosus; transcatheter closure

Year:  2013        PMID: 24570695      PMCID: PMC3915942          DOI: 10.5114/pwki.2013.34032

Source DB:  PubMed          Journal:  Postepy Kardiol Interwencyjnej        ISSN: 1734-9338            Impact factor:   1.426


Introduction

Coronary artery fistulas (CAF) are the most common anomalies of the coronary artery. Origin of the fistula from the left coronary is more common than the right (75% vs. 25%) and entry sites were in the right heart in 92% (pulmonary artery 33%, ventricle 32%, atrium 24%). Most often the entry point was a single orifice and rarely multiple. Coronary fistulas are thought to have a congenital origin and enlarge gradually throughout life [1]. The American College of Cardiology/American Heart Association 2008 guidelines for the management of adults with congenital heart diseases recommended the closure of all large coronary artery fistulas, regardless of symptomatology, using transcatheter or surgical techniques [2].

Aim

We would like to present the case of two special peculiarities: presence of patent ductus arteriosus coinciding with multiple orifices of the coronary artery fistula to the right atrium. All undesirable circulatory connections were closed during interventional catheterizations.

Case report

A 26-year-old man (68 kg body weight) was admitted with symptoms of fatigue, with continuous murmur at the left sternal border. Three months previously he was diagnosed with patent ductus arteriosus (PDA), which was closed percutaneously. The mean diameter of PDA was 4 mm, pulmonary artery pressure 21/7/12 mm Hg and aortic 100/60/70 mm Hg, Qp/Qs ratio – 3.0. Patent ductus arteriosus was type A (according to Kirchenco classification and it was closed uneventfully with a PDA 10/8 mm device (Lifetech Comp, Shenzen, China). After the procedure continuous murmur persisted. Electrocardiography was normal and in thoracic X-ray slight enlargement of the right atrium and augmented pulmonary flow in both lungs were observed. Based on the detailed transthoracic echocardiogram the presence of coronary artery fistula to the right atrium was suspected. In angio-CT left circumflex artery with possible multiple orifices to the right atrium was confirmed (Figure 1). The patient was referred for diagnostic and possible therapeutic catheterization. Written consent was obtained from the patient to perform that procedure.
Fig. 1

Computed tomography. Huge left circumflex artery to right atrium fistula (posterior view)

Computed tomography. Huge left circumflex artery to right atrium fistula (posterior view) Vascular access was obtained through the right femoral artery (sheath 6 F) and right femoral vein (sheath 8 F). Heparin and antibiotic were administered. Aortography confirmed the presence of a huge CAF to the right atrium (Figure 2). A 6 F pigtail catheter with the aid of a Terumo hydrophilic guide wire 0.35 cm × 260 cm was inserted into the dilated circumflex artery and later to the right atrium through the 6 mm orifice (Figure 3). The wire was snared using a lasso catheter in the superior vena cava (Figure 4) and exteriorized in the right femoral vein for the creation of an arteriovenous wire loop. With the 8 F delivery system the 12/10 Cardio-O-Fix (COF) PDA occluder (Starway Comp, China, Beijing) was opened (Figure 5), closing one orifice of the CAF. Another leak (orifice of CAF – 3.5 mm diameter) was closed using a similar technique by a 10/8 mm PDA COF device (Figure 6–9). Complete closure of the coronary artery fistula and disappearance of the heart murmur were observed. The patient was discharged home 4 days after the procedure on acetylsalicylic acid 150 mg/day. During 6-month follow-up he remained without any complaints or pathological symptoms. In control angio-CT complete closure of the CAF was confirmed.
Fig. 2

The same image as in Figure 1 in aortography (PA view)

Fig. 3

Crossing the fistula to right atrium with Pigtail catheter

Fig. 4

Arteriovenous loop creation

Fig. 5

Closure of the fistula with first 10/12mm Cardio- O-Fix PDA Occluder. Angiography in fistula lumen shows additional leak to right atrium is present

Fig. 6

Delivery sheath crossing another orifice of the fistula. First PDA occluder already detached in the position

Fig. 9

Final fluoroscopy. Note presence of 2 PDA occluders closing fistula (persistent contrast presence in the lumen of closed fistula), as well as third one closing PDA

The same image as in Figure 1 in aortography (PA view) Crossing the fistula to right atrium with Pigtail catheter Arteriovenous loop creation Closure of the fistula with first 10/12mm Cardio- O-Fix PDA Occluder. Angiography in fistula lumen shows additional leak to right atrium is present Delivery sheath crossing another orifice of the fistula. First PDA occluder already detached in the position Deployment of the second 10/8 mm PDA Cardio- O-Fix occluder (device still attached to delivery system) Angiography in the fistula showing almost complete occlusion Final fluoroscopy. Note presence of 2 PDA occluders closing fistula (persistent contrast presence in the lumen of closed fistula), as well as third one closing PDA

Discussion

Coronary artery fistula is an uncommon congenital malformation. Echocardiographic examination in case of CAF does not always show detailed anatomy. In such cases the usefulness of angio-CT has been confirmed in several studies [3, 4], as well as ours. Coexistence of PDA and coronary artery fistula is very rare and was described previously in one of our patients [5]. Continuous murmur is characteristic for large coronary artery fistula and was present in all previously published patients [4-8]. This murmur is present also in case of PDA, which can cloud the presence of coexisting CAF, as happened in our case. Persistent continuous murmur after successful closure of the PDA was the main reason to find out another cardiac pathology. All cases published previously [4-8] had only one fistula orifice. In the patient described in this paper, multiple (at least 2) orifices of the coronary artery fistula were present. Our experience shows that precisely chosen devices can effectively close such CAFs. Successful percutaneous closure of large coronary artery fistula has been reported previously mainly using an Amplatzer Duct Occluder (ADO) [4, 5, 8]. This implant has several advantages over other devices used to close CAFs including a high rate of complete occlusion and relatively easy implantation. On the other hand, the experience presented here, as well as by others [6, 7], indicates that Chinese devices, very similar to ADO, also fulfill these requirements. The choice of the device and technique for percutaneous closure of coronary artery fistula depends on anatomical characteristics of the fistula. Patent ductus arteriosus nitinol wire occluders are a good option for such purposes.

Conclusions

Transcatheter closure of large coronary artery fistula with multiple orifices is safe and effective.
  7 in total

1.  Successful closure for a case of congenital coronary artery fistula using a patent ductus arteriosus occluder.

Authors:  Gang Zhao; Heng Jin; Hongping Wu
Journal:  Cardiol Young       Date:  2010-10-27       Impact factor: 1.093

2.  Transcatheter occlusion of a large coronary artery fistula using a patent ductus arteriosus occluder.

Authors:  Jacek Białkowski; Małgorzata Szkutnik; Roland Fiszer; Marian Zembala
Journal:  Kardiol Pol       Date:  2011       Impact factor: 3.108

3.  The 64-slice computed tomography of a coronary artery fistula communicating with the right ventricle.

Authors:  Michał Waśniewski; Dariusz Angerer; Romuald Ochotny; Olga Trojnarska; Andrzej Szyszka; Stefan Grajek
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

4.  Transcatheter closure of a large coronary arteriovenous fistula using the new Amplatzer Duct Occluder.

Authors:  F Hakim; A Madani; Y Goussous; Q L Cao; Z M Hijazi
Journal:  Cathet Cardiovasc Diagn       Date:  1998-10

5.  [Percutaneous closure of the coronary artery fistula connecting left main coronary artery and the right atrium in a 61 year-old woman].

Authors:  Joanna Wiśniewska-Szmyt; Iwona Swiątkiewicz; Maciej Chojnicki; Marek Woźnicki; Roland Fiszer; Adam Sukiennik; Sławomir Sielski; Ewa Zabielska; Tomasz Białoszyński; Jacek Kubica
Journal:  Kardiol Pol       Date:  2011       Impact factor: 3.108

6.  Transcatheter closure of coronary artery fistula in children.

Authors:  Liang Xu; Zhong-Ying Xu; Shi-Liang Jiang; Hong Zheng; Shi-Hua Zhao; Jian Ling; Ge-Jun Zhang; Wen-Hui Wu; Shi-Guo Li; Hai-Bo Hu
Journal:  Chin Med J (Engl)       Date:  2010-04-05       Impact factor: 2.628

7.  ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Carole A Warnes; Roberta G Williams; Thomas M Bashore; John S Child; Heidi M Connolly; Joseph A Dearani; Pedro Del Nido; James W Fasules; Thomas P Graham; Ziyad M Hijazi; Sharon A Hunt; Mary Etta King; Michael J Landzberg; Pamela D Miner; Martha J Radford; Edward P Walsh; Gary D Webb
Journal:  J Am Coll Cardiol       Date:  2008-12-02       Impact factor: 24.094

  7 in total
  3 in total

1.  Transcatheter closure of ventricular septal defects with nitinol wire occluders of type patent ductus arteriosus.

Authors:  Arkadiusz Wierzyk; Małgorzata Szkutnik; Roland Fiszer; Paweł Banaszak; Szymon Pawlak; Jacek Białkowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-03-23       Impact factor: 1.426

2.  Co-existence of patent ductus arteriosus and left brachiocephalic artery: a case report.

Authors:  Mange Manyama; Erick Mazyala; William Mahalu
Journal:  J Cardiothorac Surg       Date:  2015-02-22       Impact factor: 1.637

3.  Report from the 4(th) Vietnam Congress of Congenital and Structural Heart Disease (8-10 January 2014, Saigon, Vietnam) - "Fistulas from A to Z".

Authors:  Jacek Białkowski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.